We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and profiling. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
TODAY'S HIGH
447.15
TODAY'S LOW
438
52 WEEK HIGH
1839
52 WEEK LOW
414
% of Shares Held by
All Insider
56.03%
% of Shares Held by
Institutions
16.92%
% of Float Held by
Institutions
38.48%
Number of Institutions
Holding Shares
28
MARKET CAP
1600.03 Cr.
ETERPRISE VALUE
2584.22 Cr.
NO. OF SHARES
3.59 Cr.
BOOK VALUE
429.892
DIV. YIELD
3%
DEBT
1037.36 Cr.
GROSS PROFIT
614.45 Cr.
CASH
47.25 Cr.
REVENUE
1268.34 Cr.
REVENUE/SHARE
352.91
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | -10 Lakhs | 9 Lakhs | 40 Lakhs |
| Change To Liabilities | -23.95 Cr. | 96.67 Cr. | -28.05 Cr. | -50.98 Cr. |
| Total cashflows from Investing Activities | -242.82 Cr. | -106.30 Cr. | -358.81 Cr. | -115.69 Cr. |
| Net Borrowings | 414.85 Cr. | -102.75 Cr. | 161.81 Cr. | -88.07 Cr. |
| Total Cash from Financing Activities | 333.60 Cr. | 92.49 Cr. | 96.98 Cr. | -23.39 Cr. |
| Other Liabilities | 5.23 Cr. | -29.90 Cr. | 9.59 Cr. | 105.36 Cr. |
| Total Assets | 2.93 Cr. | 298.16 Cr. | 29.76 Cr. | 44 Cr. |
| Net Income | -58.15 Cr. | 221.40 Cr. | 114.61 Cr. | 59.51 Cr. |
| Change in Cash | -151.31 Cr. | 141.65 Cr. | -19.68 Cr. | 29.77 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | -242.09 Cr. | 155.46 Cr. | 242.15 Cr. | 166.33 Cr. |
| Depreciation | 112.32 Cr. | 105.57 Cr. | 91.25 Cr. | 83.10 Cr. |
| Other Cashflows from Investing Activities | -34.36 Cr. | 65.31 Cr. | -36.23 Cr. | 52.81 Cr. |
| Dividends Paid | -10.78 Cr. | -19.73 Cr. | -15.62 Cr. | -15.62 Cr. |
| Change to Inventory | -280.53 Cr. | -15.24 Cr. | -65.79 Cr. | -24.33 Cr. |
| Change to Account Receivables | -14.55 Cr. | -257.37 Cr. | 67.80 Cr. | -55.34 Cr. |
| Other Cashflows from Financing Activities | -73.40 Cr. | -83.19 Cr. | -78.97 Cr. | 20.68 Cr. |
| Change to Net Income | 17.54 Cr. | 31.24 Cr. | 49.83 Cr. | 49.01 Cr. |
| Capital Expenditures | -208.59 Cr. | -174.48 Cr. | -268.87 Cr. | -59 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | -91.10 Cr. | 221.50 Cr. | 114.91 Cr. | 67.67 Cr. |
| Minority Interest | 2.31 Cr. | 4.24 Cr. | 4.29 Cr. | 4.38 Cr. |
| Net Income | -32.35 Cr. | 284.60 Cr. | 173.18 Cr. | 147.52 Cr. |
| Selling General Administrative | 236.34 Cr. | 232.65 Cr. | 207.98 Cr. | 192.68 Cr. |
| Gross Profit | 614.45 Cr. | 846.43 Cr. | 675.24 Cr. | 632.23 Cr. |
| Ebit | -32.35 Cr. | 284.60 Cr. | 173.18 Cr. | 147.52 Cr. |
| Operating Income | -32.35 Cr. | 284.60 Cr. | 173.18 Cr. | 147.52 Cr. |
| Other Operating Expenses | 298.14 Cr. | 220.52 Cr. | 199.92 Cr. | 208.93 Cr. |
| Interest Expense | -75.28 Cr. | -80.34 Cr. | -75.23 Cr. | -73.09 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | -32.81 Cr. | 15 Lakhs | 39 Lakhs | 58 Lakhs |
| Total Revenue | 1268.34 Cr. | 1616.88 Cr. | 1321.75 Cr. | 1386.68 Cr. |
| Total Operating Expenses | 1300.69 Cr. | 1332.28 Cr. | 1148.57 Cr. | 1239.16 Cr. |
| Cost of Revenue | 653.89 Cr. | 770.45 Cr. | 646.51 Cr. | 754.45 Cr. |
| Total Other Income Expense Net | -58.75 Cr. | -63.10 Cr. | -58.27 Cr. | -79.85 Cr. |
| Discontinued Operations | 0 | 0 | 0 | -7.68 Cr. |
| Net Income from Continuous Ops. | -58.29 Cr. | 221.35 Cr. | 114.52 Cr. | 67.09 Cr. |
| Net Income Applicable to Common Shares | -58.15 Cr. | 221.40 Cr. | 114.61 Cr. | 53.74 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 67.94 Cr. | 79.98 Cr. | 92.28 Cr. | 102.89 Cr. |
| Capital Surplus | 0 | 1211.72 Cr. | 820.55 Cr. | 780.61 Cr. |
| Total Liabilities | 1425.29 Cr. | 1020.82 Cr. | 1063.27 Cr. | 999.80 Cr. |
| Stock Holder Equity | 1524.90 Cr. | 1588.52 Cr. | 1085.94 Cr. | 955.87 Cr. |
| Minority Interest | 2.31 Cr. | 4.24 Cr. | 4.29 Cr. | 4.38 Cr. |
| Other Liabilities | 40.36 Cr. | 19.15 Cr. | 30.57 Cr. | 95.98 Cr. |
| Total Assets | 2952.50 Cr. | 2613.58 Cr. | 2153.50 Cr. | 1960.05 Cr. |
| Common Stock | 36 Cr. | 35.92 Cr. | 26.85 Cr. | 25.77 Cr. |
| Retained Earnings | 0 | 338.85 Cr. | 139.70 Cr. | 44.57 Cr. |
| Other Liabilities | 60.62 Cr. | 65.47 Cr. | 87.86 Cr. | 119.28 Cr. |
| Good Will | 365.09 Cr. | 365.09 Cr. | 365.09 Cr. | 365.09 Cr. |
| Treasury Stock | 1488.90 Cr. | 2.03 Cr. | 98.84 Cr. | 104.92 Cr. |
| Other Assets | 142.38 Cr. | 111.26 Cr. | 72.26 Cr. | 82.61 Cr. |
| Cash | 47.25 Cr. | 197.69 Cr. | 56.04 Cr. | 75.72 Cr. |
| Current Liabilities | 1070.93 Cr. | 788.75 Cr. | 729.89 Cr. | 655.50 Cr. |
| Long Term Asset Charges | 55.14 Cr. | 25.61 Cr. | 7 Lakhs | 7 Lakhs |
| Short Long Term Debt | 741.53 Cr. | 91.20 Cr. | 120.29 Cr. | 98.33 Cr. |
| Other Stockholder Equity | 1488.90 Cr. | 2.03 Cr. | 98.84 Cr. | 104.92 Cr. |
| Property Plant Equipment | 1137.39 Cr. | 999.20 Cr. | 951.56 Cr. | 760.95 Cr. |
| Total Cur. Assets | 1239.28 Cr. | 1057.63 Cr. | 671.99 Cr. | 648.10 Cr. |
| Long Term Investments | 42 Lakhs | 42 Lakhs | 32 Lakhs | 41 Lakhs |
| Net Tangible Assets | 1091.87 Cr. | 1143.45 Cr. | 628.57 Cr. | 487.89 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 550.78 Cr. | 542.80 Cr. | 311.42 Cr. | 334.14 Cr. |
| Long Term Debt | 283.04 Cr. | 154.83 Cr. | 232.76 Cr. | 221.21 Cr. |
| Inventory | 575.55 Cr. | 294.97 Cr. | 279.73 Cr. | 230.84 Cr. |
| Accounts Payable | 283.50 Cr. | 309.30 Cr. | 216.12 Cr. | 244.38 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account